Evidence map›Paper›PMID 39413134›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

BLNK negatively regulates innate antifungal immunity through inhibiting c-Cbl-mediated macrophage migration.

Yi-Heng Yang, Ke-Fang Xie, Shuai Yang, Huan Wang, Hui-Hui Ma, Min Zhou, Zhong-Wei Wang, Yebo Gu, Xin-Ming Jia

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi-Heng YangDepartment of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.ORCID 0009-0007-4687-1775
Ke-Fang XieDepartment of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Shuai YangDepartment of Infection and Immunity, Clinical Medicine Scientific and Technical Innovation Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.
Huan WangKey Laboratory of Yangtze River Water Environment, Ministry of Education, College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.
Hui-Hui MaDepartment of Infection and Immunity, Clinical Medicine Scientific and Technical Innovation Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.ORCID 0000-0002-1904-6901
Min ZhouDepartment of Periodontology, Stemmatological Hospital, Tongji University, Shanghai 200072, China.ORCID 0000-0002-6831-3033
Zhong-Wei WangDepartment of Infection and Immunity, Clinical Medicine Scientific and Technical Innovation Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.
Yebo GuDepartment of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.ORCID 0000-0002-9612-3763
Xin-Ming JiaDepartment of Infection and Immunity, Clinical Medicine Scientific and Technical Innovation Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China.ORCID 0000-0002-7245-5560

Funding

MOST | National Key Research and Development Program of China (NKPs) 2021YFC2300400MOST | National Key Research and Development Program of China (NKPs) 2022YFC2303000MOST | National Key Research and Development Program of China (NKPs) 2023YFF0613602MOST | National Natural Science Foundation of China (NSFC) 82371777Shanghai Municipal Health Commission () 20224Z0020Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Foundation) 22YF1433900
6 · The paper itself

Abstract

B cell linker protein (BLNK) is crucial for orchestrating B cell receptor-associated spleen tyrosine kinase (Syk) signaling. However, the role of BLNK in Syk-coupled C-type lectin receptor (CLR) signaling in macrophages remains unclear. Here, we delineate that CLRs govern the Syk-mediated activation of BLNK, thereby impeding macrophage migration by disrupting podosome ring formation upon stimulation with fungal β-glucans or α-mannans. Mechanistically, BLNK instigates its association with casitas B-lineage lymphoma (c-Cbl), competitively impeding the interaction between c-Cbl and Src-family kinase Fyn. This interference disrupts Fyn-mediated phosphorylation of c-Cbl and subsequent c-Cbl-associated F-actin assembly. Consequently, BLNK deficiency intensifies CLR-mediated recruitment of the c-Cbl/phosphatidylinositol 3-kinase complex to the F-actin cytoskeleton, thereby enhancing macrophage migration. Notably, mice with monocyte-specific BLNK deficiency exhibit heightened resistance to infection with

Indexed as

Candida albicansCandidiasisCell MovementImmunity, InnateMacrophagesProto-Oncogene Proteins c-cblSyk KinaseAdaptor Proteins, Signal TransducingAnimalsLectins, C-TypeMiceMice, Inbred C57BLMice, KnockoutPhosphorylationPodosomesProto-Oncogene Proteins c-fynAdaptor Proteins, Signal TransducingB cell linker proteinCbl protein, mouseLectins, C-TypeProto-Oncogene Proteins c-cblProto-Oncogene Proteins c-fynSyk KinaseSyk protein, mouseantifungal immunityB cell linker proteinC-type lectin receptorsmacrophage migrationnegative regulation

Identifiers

PMID39413134
PMCPMC11513953

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.